Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action

Endocrinology. 2004 Sep;145(9):4344-54. doi: 10.1210/en.2004-0234. Epub 2004 Jun 10.

Abstract

The functional involvement of bone morphogenetic protein (BMP) system in primary pulmonary hypertension (PPH) remains unclear. Here we demonstrate a crucial role of the BMP type IB receptor, activin receptor-like kinase (ALK)-6 for pulmonary arterial smooth muscle cell (pphPASMC) mitosis isolated from a sporadic PPH patient bearing no mutations in BMPR2 gene. A striking increase in the levels of ALK-6 mRNA was revealed in pphPASMC compared with control PASMCs, in which ALK-6 transcripts were hardly detectable. BMP-2 and -7 stimulated the mitosis of pphPASMCs, which was opposite to their suppressive effects on the mitosis of the control PASMCs. BMP-4 and -6 and activin inhibited pphPASMC mitosis, whereas these did not affect control PASMCs. The presence of BMP signaling machinery in pphPASMCs was elucidated based on the analysis on Id-1 transcription and Smad-reporter genes. Overexpression of a dominant-negative ALK-6 construct revealed that ALK-6 plays a key role in the mitosis as well as intracellular BMP signaling of pphPASMCs. Gene silencing of ALK-6 using small interfering RNA also reduced DNA synthesis as well as Id-1 transcription in pphPASMCs regardless of BMP-2 stimulation. Although Id-1 response was not stimulated by BMP-2 in control PASMCs, the gene delivery of wild-type ALK-6 caused significant increase in the Id-1 transcripts in response to BMP-2. Additionally, inhibitors of ERK and p38 MAPK pathways suppressed pphPASMC mitosis induced by BMP-2, implying that the mitotic action is in part MAPK dependent. Thus, the BMP system is strongly involved in pphPASMC mitosis through ALK-6, which possibly leads to activation of Smad and MAPK, resulting in the progression of vascular remodeling of pulmonary arteries in PPH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Morphogenetic Protein Receptors, Type I
  • Bone Morphogenetic Proteins / pharmacology*
  • Butadienes / pharmacology
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Hypertension, Pulmonary / physiopathology*
  • Imidazoles / pharmacology
  • Ligands
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Mitosis / drug effects
  • Mitosis / physiology
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / physiology*
  • Nitriles / pharmacology
  • Protein Serine-Threonine Kinases / genetics*
  • Protein Serine-Threonine Kinases / metabolism
  • Pulmonary Artery / cytology
  • Pulmonary Artery / physiology*
  • Pyridines / pharmacology
  • RNA, Messenger / analysis
  • Receptors, Growth Factor / genetics*
  • Receptors, Growth Factor / metabolism

Substances

  • Bone Morphogenetic Proteins
  • Butadienes
  • Enzyme Inhibitors
  • Imidazoles
  • Ligands
  • Nitriles
  • Pyridines
  • RNA, Messenger
  • Receptors, Growth Factor
  • U 0126
  • Protein Serine-Threonine Kinases
  • BMPR1B protein, human
  • Bone Morphogenetic Protein Receptors, Type I
  • SB 203580